Current Challenges in Gynecologic and Obstetric Pathology: A Sailing Guide

About This CME Teaching Activity

This CME teaching activity will provide updates in gynecologic and obstetric pathology emphasizing why and how to incorporate new knowledge and recommendations into routine practice. Sessions will immerse the audience in the novelties and shifts of the new 2025 World Health Organization classification of female genital tract tumours, as well as current staging recommendations (FIGO, AJCC) and management guidelines (NCCN, ESGO/ESTRO/ESP). Three slide seminars will prepare the audience to correctly identify and appraise challenging forms of endometrial, cervical and vulvo-vaginal neoplasia; one additional slide seminar will allow the audience to develop a practical approach to intraoperative evaluation of ovarian tumours. Two sessions will be devoted to the landscape of molecular classification of endometrial cancer, and biomarker testing in gynecologic malignancies for prognostic or therapeutic purposes (Her2, PD-L1, HRD, FR-alpha). A dedicated session on placental pathology will focus on known and emerging lesions that the pathologist should be aware of based on their relevance in predicting future morbidity, correlating with obstetric outcomes, or requiring immediate medical intervention.

Target Audience

This CME activity is primarily aimed at pathologists who encounter gynecologic and obstetric cases in their practice, as well as pathologists training in the field of gynecologic pathology.

Educational Objectives

At the completion of this CME teaching activity, you should be able to:

• Recognize clinically relevant placental conditions that carry a clinical risk for complications, recurrence in future gestations, or require immediate management.
• Understand the major changes in female genital tract neoplasia classification introduced by the 2025 World Health Classification.
• Appraise the current recommendations on molecular and immunohistochemical testing of gynecologic cancers for classification, prognostic and therapeutic purposes.
• Recognize the morphologic spectrum of high-grade endometrial and ovarian carcinoma and the importance of each recognized type in light of pathogenesis, prognosis, and management.
• Identify types of uterine mesenchymal neoplasia with malignant potential, distinguishing them from benign lesions and impacting patient care.
• Develop a practical approach to the evaluation of vulvo-vaginal and cervical squamous neoplasia, endocervical glandular lesions and miscellaneous (melanocytic, mesenchymal) diseases in the lower female genital tract.

No special educational preparation is required for this CME activity.

USB Cancellation Policy

We offer a 15-day evaluation period to ensure the product meets your needs. If you are not satisfied, you may receive a refund within 15 days. Cancellations must be received in writing. Please note, there will be a $125.00 processing fee as well as shipping charges applied to all refunds. No credit can be applied on returned purchases. (Two or more returns void the cancellation policy.)

On-Demand Cancellation Policy

We offer a 15-day evaluation period to ensure the product meets your needs. If you are not satisfied, you may receive a refund within 15 days if you have watched less than 20% of your purchase. Cancellations must be received in writing.